Targeting plasma membrane GRP78 for cancer growth inhibition

Cancer Biol Ther. 2010 Jan;9(2):153-5. doi: 10.4161/cbt.9.2.10760. Epub 2010 Jan 26.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology*
  • Adenocarcinoma / therapy
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use
  • Antigens, Neoplasm / immunology*
  • Antigens, Surface / immunology*
  • Apoptosis / immunology
  • Caspases / metabolism
  • Cell Line, Tumor / drug effects
  • Drug Delivery Systems*
  • Endoplasmic Reticulum Chaperone BiP
  • Enzyme Activation / drug effects
  • Heat-Shock Proteins / antagonists & inhibitors
  • Heat-Shock Proteins / chemistry
  • Heat-Shock Proteins / immunology
  • Heat-Shock Proteins / physiology*
  • Humans
  • Immunotherapy*
  • Male
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / chemistry
  • Neoplasm Proteins / immunology
  • Neoplasm Proteins / physiology*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy
  • Protein Kinases / physiology*
  • Protein Structure, Tertiary
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Antigens, Surface
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Heat-Shock Proteins
  • Neoplasm Proteins
  • Protein Kinases
  • Caspases